Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
4000 participants
OBSERVATIONAL
2021-06-15
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pulmonary Complications of Allografts
NCT01219972
Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
NCT05866302
Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
NCT00106925
Impact of Pulmonary Follow-up After Stem Cell Graft
NCT03349372
Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202)
NCT01879072
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Lung transplant recipients who have previously enrolled in the LTOG cohort studies at one of the participating centers
Long-term functional status and well-being
* Lung transplant recipients who have previously enrolled in the LTOG cohort studies at one of the participating centers
* Alive
Exclusion Criteria
* Lung transplant recipient not enrolled in LTOG cohort research studies
Long-term functional status and well-being
* Lung transplant recipient not enrolled in the LTOG cohort research studies
* Lung transplant recipient not receiving post-transplant follow-up care at a participating LTOG center
13 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Columbia University
OTHER
University of Alabama at Birmingham
OTHER
Stanford University
OTHER
Johns Hopkins University
OTHER
University of Michigan
OTHER
University of Pittsburgh
OTHER
Duke University
OTHER
Indiana University
OTHER
University of California, San Francisco
OTHER
University of Pennsylvania
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jason Christie, MD
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Scott Palmer, MD
Role: PRINCIPAL_INVESTIGATOR
Duke University
Jonathan Singer, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama Birmingham
Birmingham, Alabama, United States
University of California San Francisco
San Francisco, California, United States
Stanford University
Stanford, California, United States
Indiana University
Indianapolis, Indiana, United States
Johns Hopkins University
Baltimore, Maryland, United States
University of Michigan
Ann Arbor, Michigan, United States
Columbia University
New York, New York, United States
Duke University
Durham, North Carolina, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
834898
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.